Quick search
Advanced search in
Research outcomes
Field to searchTerm
[TRANSVAC2] European Vaccine Research and Development Infrastructure (730964)
Add rule
Filters
Filters

COVID-19 Publications

Filters

COVID-19 Publications

The following results are related to COVID-19. Are you interested to view more results? Visit OpenAIRE - Explore.
Download Results
11 research outcomes, page 1 of 2
  • publication . Article . Preprint . 2022
    Open Access English
    Authors:
    Guidenn Sulbaran; Pauline Maisonnasse; Axelle Amen; Delphine Guilligay; Nathalie Dereuddre-Bosquet; Judith A. Burger; Meliawati Poniman; M. Buisson; Sebastian Dergan Dylon; Thibaut Naninck; ...
    Persistent Identifiers
    Countries: Netherlands, France, France, France
    Project: EC | TRANSVAC2 (730964), EC | EVAg (653316), EC | EHVA (681032)

    The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has caused an ongoing global health crisis. Here, we present as a vaccine candidate synthetic SARS-CoV-2 spike (S) glycoprotein-coated lipid vesicles that resemble virus-like particles. Soluble S ...

    Add to ORCIDorcid
  • publication . Article . 2021
    Open Access English
    Authors:
    Romain Marlin; Véronique Godot; Sylvain Cardinaud; Mathilde Galhaut; Severin Coleon; Sandra Zurawski; Nathalie Dereuddre-Bosquet; Mariangela Cavarelli; Anne-Sophie Gallouet; Pauline Maisonnasse; ...
    Persistent Identifiers
    Publisher: HAL CCSD
    Country: France
    Project: EC | EVAg (653316), ANR | IDMIT (ANR-11-INBS-0008), EC | TRANSVAC2 (730964)

    Achieving sufficient worldwide vaccination coverage against SARS-CoV-2 will require additional approaches to currently approved viral vector and mRNA vaccines. Subunit vaccines may have distinct advantages when immunizing vulnerable individuals, children and pregnant wo...

    Add to ORCIDorcid
  • publication . Article . 2021
    Open Access English
    Authors:
    Pauline Maisonnasse; Yoann Aldon; Aurélien Marc; Romain Marlin; Nathalie Dereuddre-Bosquet; Natalia Kuzmina; Alec W. Freyn; Jonne L. Snitselaar; Antonio Gonçalves; Tom G. Caniels; ...
    Persistent Identifiers
    Publisher: Nature Portfolio
    Country: Netherlands
    Project: ANR | IDMIT (ANR-11-INBS-0008), EC | TRANSVAC2 (730964)

    Effective treatments against Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) are urgently needed. Monoclonal antibodies have shown promising results in patients. Here, we evaluate the in vivo prophylactic and therapeutic effect of COVA1-18, a neutralizing a...

    Add to ORCIDorcid
  • publication . Article . 2021
    Open Access English
    Authors:
    Margarida Q. Rodrigues; Paula M. Alves; António Roldão;
    Project: EC | TRANSVAC2 (730964)

    In the last decade, the interest in ferritin-based vaccines has been increasing due to their safety and immunogenicity. Candidates against a wide range of pathogens are now on Phase I clinical trials namely for influenza, Epstein-Barr, and SARS-CoV-2 viruses. Manufactur...

    Add to ORCIDorcid
  • publication . Article . 2021
    Open Access English
    Authors:
    Nerea Zabaleta; Wenlong Dai; U. Bhatt; Cécile Hérate; Pauline Maisonnasse; Jessica A. Chichester; Julio Sanmiguel; Reynette Estelien; Kristofer T. Michalson; Cheikh Talibouya Diop; ...
    Persistent Identifiers
    Publisher: The Author(s). Published by Elsevier Inc.
    Project: EC | TRANSVAC2 (730964)

    The SARS-CoV-2 pandemic has affected more than 185 million people worldwide resulting in over 4 million deaths. To contain the pandemic, there is a continued need for safe vaccines that provide durable protection at low and scalable doses and are easily delivered. Here,...

    Add to ORCIDorcid
  • publication . Article . 2021
    Open Access
    Authors:
    Julien Lemaitre; Thibaut Naninck; Benoit Delache; Justina Creppy; Philippe Huber; Marion Holzapfel; Camille Bouillier; Vanessa Contreras; Frédéric Martinon; Nidhal Kahlaoui; ...
    Persistent Identifiers
    Publisher: Elsevier BV
    Project: EC | TRANSVAC2 (730964)

    Respiratory pathogens represent a great burden for humanity and a potential source of new pandemics, as illustrated by the recent emergence of coronavirus disease 2019 (COVID-19). In recent decades, biotechnological advances have led to the development of numerous innov...

    Add to ORCIDorcid
  • publication . Article . Preprint . 2021
    Open Access
    Authors:
    Philip J. M. Brouwer; Mitch Brinkkemper; Pauline Maisonnasse; Nathalie Dereuddre-Bosquet; Marloes Grobben; Mathieu Claireaux; Marlon de Gast; Romain Marlin; Virginie Chesnais; Ségolène Diry; ...
    Publisher: Cold Spring Harbor Laboratory
    Countries: United Kingdom, Netherlands
    Project: EC | TRANSVAC2 (730964)

    The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic is continuing to disrupt personal lives, global healthcare systems, and economies. Hence, there is an urgent need for a vaccine that prevents viral infection, transmission, and disease. Here, we p...

    Add to ORCIDorcid
  • publication . Article . 2020
    Open Access English
    Authors:
    Annalisa Ciabattini; Paolo Garagnani; Francesco Santoro; Rino Rappuoli; Claudio Franceschi; Donata Medaglini;
    Persistent Identifiers
    Country: Italy
    Project: EC | TRANSVAC2 (730964)

    AbstractThe SARS-CoV-2 pandemic urgently calls for the development of effective preventive tools. COVID-19 hits greatly the elder and more fragile fraction of the population boosting the evergreen issue of the vaccination of older people. The development of a vaccine ag...

    Add to ORCIDorcid
  • publication . Article . 2020
    Open Access English
    Authors:
    Pauline Maisonnasse; Jeremie Guedj; Vanessa Contreras; Sylvie Behillil; Caroline Solas; Romain Marlin; Thibaut Naninck; Andrés Pizzorno; Julien Lemaitre; Antonio Gonçalves; ...
    Persistent Identifiers
    Country: France
    Project: EC | Fight-nCoV (101003555), EC | EVAg (653316), ANR | IDMIT (ANR-11-INBS-0008), EC | EVA-GLOBAL (871029), EC | TRANSVAC2 (730964), EC | CARE (101005077)

    International audience; Coronavirus disease 2019 (COVID-19) has rapidly become a global pandemic and no antiviral drug or vaccine is yet available for the treatment of this disease1-3. Several clinical studies are ongoing to evaluate the efficacy of repurposed drugs tha...

    Add to ORCIDorcid
  • publication . Article . 2020
    Open Access English
    Authors:
    Simon G. P. Funnell; W. E. Dowling; César Muñoz-Fontela; Pierre Stéphane Gsell; Donald E. Ingber; G. A. Hamilton; Leen Delang; Joana Rocha-Pereira; Suzanne J.F. Kaptein; Kai Dallmeier; ...
    Persistent Identifiers
    Publisher: HAL CCSD
    Countries: Belgium, France
    Project: NIH | Lung-on-a-Chip Disease Mo... (1UG3HL141797-01), EC | EVAg (653316), EC | EVA-GLOBAL (871029), EC | TRANSVAC2 (730964), ANR | IDMIT (ANR-11-INBS-0008)

    International audience; There is an urgent need for drugs, therapies and vaccines to be available to protect the human population against COVID-19. One of the first approaches taken in the COVID-19 global response was to consider repurposing licensed drugs. This comment...

    Add to ORCIDorcid
11 research outcomes, page 1 of 2